Every year, the Vaincre Alzheimer Foundation publishes a report on medical research specializing in Alzheimer’s disease. This report presents the main scientific advances of the year concerning this pathology. The Vaincre Alzheimer Foundation, a scientific reference in France, makes news on research progress accessible to all. This is why, this year, Vaincre Alzheimer is publishing its 2024 report on medical research specializing in Alzheimer’s disease.
In the 2023 report, the Foundation took stock of new therapies. She notably presented the This group© and the shelterTMpromising anti-amyloid treatments, already on the market in the United States.
This year, the Vaincre Alzheimer Foundation has chosen to take stock of the diagnosis of the disease.
2024 report: focus on the diagnosis of Alzheimer’s disease
Treatments shelterTM et This group© underline the importance of diagnosing Alzheimer’s disease early for greater effectiveness. These immunotherapies are most effective when administered in the early stages. However, in France, almost one in two patients is not or incorrectly diagnosed. It is therefore important to take stock of the diagnostic pathway for Alzheimer’s disease in France and the latest scientific advances in the field.
Diagnosis of Alzheimer’s disease: what the 2024 report reveals
This 2024 report on medical research specializing in Alzheimer’s disease traces the evolution of diagnostic criteria and methods. It starts from the first criteria of the 1980s based on symptoms up to the latest diagnostic criteria, mainly biological, relayed by the American NGOAlzheimer Association in 2024. The report compares the theoretical diagnostic pathway in France with the current reality. It also underlines the importance of the central role of general practitioners in making this journey smoother.
Finally, this report also presents recent major advances in the diagnosis of Alzheimer’s disease. The report details progress on blood biomarkers, which will soon be integrated into the diagnostic pathway in France. Artificial intelligence is also an avenue of research that scientists are exploring to improve early diagnosis and differentiate neurocognitive diseases.
Related News :